Home › Funds › Distillate Capital Partners LLC › ABBV

Distillate Capital Partners LLC position in ABBV

ABBVIE INC · Health Care

Distillate Capital Partners LLC reported holding 158,072 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$41.4M, representing 1.97% of its reported portfolio and ranking #4 among its reported holdings. Distillate Capital Partners LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)158.07K sh
Reported value held$41.35M
Portfolio Weight1.97%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Distillate Capital Partners LLC's ABBV position evolved

Distillate Capital Partners LLC first disclosed a stake in ABBV in Q3 2023 at 80 shares (US$12K). The position peaked in Q3 2024 at 287,798 shares, worth US$56.8M. Across 13 filings, Distillate Capital Partners LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 158,072 shares valued at US$41.4M — an increase of 3,289 shares quarter over quarter.. Notable position changes include a 364292% increase in Q2 2024 (shares rose 16% over the following quarter), a 41% trim in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 80 $11.93K New
Q4 2023 80 $12.40K Hold
Q1 2024 80 $14.57K Hold
Q2 2024 291.51K $50.00M Add
Q3 2024 287.80K $56.82M Reduce
Q4 2024 314.60K $55.90M Add
Q1 2025 253.59K $53.13M Reduce
Q2 2025 229.20K $42.54M Reduce
Q3 2025 226.32K $52.42M Reduce
Q4 2025 219.69K $50.20M Reduce
Q1 2026 260.37K $56.63M Add
Q2 2026 154.78K $38.95M Reduce
Q3 2026 158.07K $41.35M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 32 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Distillate Capital Partners LLC held ABBV?

Distillate Capital Partners LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Distillate Capital Partners LLC's current position in ABBV?

As of Q3 2026, Distillate Capital Partners LLC holds 158.07K shares of ABBV (ABBVIE INC), valued at $41.35M, representing 1.97% of its reported portfolio and ranking #4.

Has Distillate Capital Partners LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Distillate Capital Partners LLC increased its position in ABBV. The position peaked in Q3 2024 at 287.80K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.